Navigation Links
Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole'
Date:11/6/2009

WINNIPEG, Manitoba, Nov. 6 /PRNewswire/ -- With his proposed health care reform plan, President Barack Obama has set his sights on cutting name-brand prescription drug costs by 50 percent for Medicare patients who fall into the "Part D" coverage gap, universally known as the "donut hole." Plan advocates rave about the potential cost-cutting and feel it's a promising start to health care reform. Yet some of the most powerful lobbyists want a revised program that completely eliminates the donut hole, which prevents Medicare coverage between two points of spending. This approach would cost the federal government $134 billion over a 10-year period. And while the various sides debate the details, most people don't realize that a solution already exists. There's an option for even greater savings that's gap-free and available right now.

Betterthanmedicare.com (http://www.betterthanmedicare.com) is an alternative to Medicare - and high drug prices in general - and offers discounts of up to 85 percent off many top brands. Leveraging the power of its relationships with leading pharmaceutical suppliers, Betterthanmedicare.com passes these low prices directly to consumers, enabling them to save thousands of dollars annually. In fact, these savings are available to everyone, not just patients over 65 or on Medicare. There are no restrictions on who qualifies to enroll in Betterthanmedicare.com. It's all-inclusive, with no gimmicks or coverage gaps.

A look at one customer, Mary, provides the perfect illustration of how Betterthanmedicare.com's program works. This particular patient takes one 75-mg Plavix tablet daily, one 20-mg Lipitor tablet and a 200-mg capsule of Celebrex. Regular retail costs would run her $4,860 annually, but she's on Medicare, so she spends $3,056 for out-of-pocket prescription expenses. With Betterthanmedicare.com, however, Mary spends only $860 a year - $2,200 less
'/>"/>

SOURCE Betterthanmedicare.com
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Innovative Psoriasis Treatment PSORENT(R) Announces Healthcare Cost Savings Potential Consistent with President Obamas Announcement on Healthcare Reform
2. Open Letter to President-Elect Barack Obama From Don Margolis, Chairman and Founder of The Repair Stem Cell Institute
3. Mindset Media Study Reveals Which Independent Voters Favor Obama Vs. McCain
4. Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors
5. Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
6. BD to Present at Investor Healthcare Conferences
7. BioMarin to Present at the Credit Suisse Healthcare Conference
8. Gentiva(R) Health Services to Present at the Credit Suisse Healthcare Conference
9. Quest Diagnostics To Speak At The Oppenheimer 20th Annual Healthcare Conference
10. Arcadia Resources to Present at Lazard Healthcare Conference in New York
11. HealthSouth to Present at 6th Annual Lazard Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY ... tender offer for all outstanding shares of common stock ... offer and withdrawal rights expired at 12:00 midnight, ... 2010 .  The depositary for the tender offer has ... 18,611,072 shares of Chattem common stock (including approximately 2,853,283 ...
(Date:2/8/2010)... Feb. 8 Rapid developments in ... increase in the use and cost of "specialty" ... and psoriasis. This has led to some inappropriate ... and medication coverage being spread over both pharmacy ... solution with Medication Cost Integration (MCI), which covers ...
(Date:2/8/2010)... 8 Transgenomic, Inc. (OTC Bulletin ... a preliminary study with a leading pharmaceutical company ... technology to detect colorectal tumor-associated KRAS mutations that ... detected in plasma samples in which the mutation ... DNA analysis methodologies such as Sanger sequencing. ,, ...
Breaking Medicine Technology:Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 2Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 3Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 4Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 5RegenceRx Leads the Industry With Introduction of Medication Cost Integration 2RegenceRx Leads the Industry With Introduction of Medication Cost Integration 3Transgenomic Demonstrates Very High Sensitivity Detection of Tumor-Associated KRAS Mutations in Matched Plasma Samples Using COLD-PCR 2Transgenomic Demonstrates Very High Sensitivity Detection of Tumor-Associated KRAS Mutations in Matched Plasma Samples Using COLD-PCR 3Transgenomic Demonstrates Very High Sensitivity Detection of Tumor-Associated KRAS Mutations in Matched Plasma Samples Using COLD-PCR 4 26quot 3BJesse 26apos 3Bs Story 26quot 3B to Open The 10th Annual Malibu Film Festival 53500 1 26quot 3BJesse 26apos 3Bs Story 26quot 3B to Open The 10th Annual Malibu Film Festival 53500 2 26quot 3BJesse 26apos 3Bs Story 26quot 3B to Open The 10th Annual Malibu Film Festival 53500 3U S Fund for UNICEF and Major League Soccer Kick Off Partnership to Save Childrens Lives 53499 1U S Fund for UNICEF and Major League Soccer Kick Off Partnership to Save Childrens Lives 53499 2U S Fund for UNICEF and Major League Soccer Kick Off Partnership to Save Childrens Lives 53499 3Leading U S Expert Offers Ten Warning Signs and Symptoms of Mental Health Problems in Elderly 53497 1Leading U S Expert Offers Ten Warning Signs and Symptoms of Mental Health Problems in Elderly 53497 2Leading U S Expert Offers Ten Warning Signs and Symptoms of Mental Health Problems in Elderly 53497 3
... Study Also Showed Arzoxifene Significantly Suppressed Bone Turnover ... Greece, March 23 Eli Lilly and Company ... showing arzoxifene, an investigational selective estrogen receptor modulator ... mineral density (BMD) in the lumbar spine, total ...
... YORK, March 20 InnoCentive, Inc., ... Publishing Group (NPG) , a leading scientific and ... greater scientific collaboration and open innovation.Under the agreement, ... the involvement of scientists worldwide in solving global ...
Other Medicine Technology:Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 2Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 3Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 4Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 5InnoCentive and Nature Publishing Group Announce Partnership to Facilitate Open Innovation 2InnoCentive and Nature Publishing Group Announce Partnership to Facilitate Open Innovation 3InnoCentive and Nature Publishing Group Announce Partnership to Facilitate Open Innovation 4
(Date:2/9/2010)... WEST PALM BEACH, Fla. , Feb. 9 /PRNewswire-USNewswire/ ... a grant awarded to the School District of Palm ... eat right and get fit. The Robert Wood Johnson Foundation ... opportunities for physical activity and access to affordable healthy foods ... and Palm Springs communities. Based on a rigorous ...
(Date:2/9/2010)... iPhone application created by UH researchers is providing ... world. Those annual rankings of America,s fattest and ... host of indirect indicators may soon have a ... the University of Houston provides objective data. , ... from Apple,s "App Store," allows users to keep ...
(Date:2/9/2010)... increased in infants born prematurely in the US, according ... System (LUHS). These findings were reported at the 30th ... Chicago. They also were published in the latest issue ... . , Researchers reported that CP is associated with ... This inflammation is more common in premature births from ...
(Date:2/9/2010)... type II audit is a significant achievement and differentiates ... , ... (PRWEB) February 9, 2010 ... announced that it has successfully completed a Statement on Auditing ... by McGladrey & Pullen, LLP and covered Hallmark Insights operational ...
(Date:2/9/2010)... men with fewer complications, study finds , , TUESDAY, Feb. ... are more likely than men to fail catheter ablation ... procedures five times as often as women and usually ... February issue of HeartRhythm Journal , are based ... and 2008. They underwent pulmonary vein antrum isolation, a ...
Breaking Medicine News(10 mins):Health News:Planting Seeds to Fight Childhood Obesity 2Health News:Phone app providing real-time statistics on physical activity around the world 2Health News:Phone app providing real-time statistics on physical activity around the world 3Health News:Incidence of cerebal palsy on rise in United States 2Health News:Hallmark Insights Completes SAS 70 Type II Audit 2
... Three studies to be presented at Teenage Cancer Trust,s Fifth ... (Monday) have thrown light on the extent of delays that ... with cancer, and on some of the reasons why this ... Cancer at the University of Manchester, UK, will tell the ...
... to 75 with type 2 disease have same odds for condition, ... adults with type 2 diabetes run much less risk than previously ... to the heart, according to a new study. , ... diabetes run the same risk of having a cardiac condition whether ...
... presenting with one checked for other , , SATURDAY, ... between type 2 diabetes and obstructive sleep apnea (OSA) ... the International Diabetes Federation warns. , Up to 40 ... also have diabetes, recent studies suggest. Likewise, more than ...
... Echocardiography System to Acquire, Instantaneous, Non-Stitched Full-Volume Images of the ... ... Heartbeat, TORONTO, June 7 Siemens Healthcare, (http://www.usa.siemens.com/healthcare ) ... the world to acquire,non-stitched, real-time full-volume 3D images of the heart ...
... Event Becomes "Susan G. Komen GLOBAL Race for ... National Mall was,passionately pink this morning, as nearly ... for the 19th annual Susan,G. Komen National Race ... to fund breast cancer research and community health ...
... Renhuang,Pharmaceuticals, Inc. (Pink Sheets: RHGP) ("Renhuang" or "the ... of China ("PRC"),today announced the successful completion of ... May 29, 2008., Tianma pills, one of ... the treatment of headaches. The primary,active ingredient in ...
Other Medicine News:Health News:Teenagers and young adults with cancer can face long delays before finally being diagnosed 2Health News:Teenagers and young adults with cancer can face long delays before finally being diagnosed 3Health News:Teenagers and young adults with cancer can face long delays before finally being diagnosed 4Health News:Older Diabetics' Risk of Cardiac Ischemia Lower Than Thought 2Health News:Doctors Urged to Look for Link Between Type 2 Diabetes, Sleep Apnea 2Health News:Siemens' New Ultrasound Platform Revolutionizes the Paradigm of Echocardiography 2Health News:Siemens' New Ultrasound Platform Revolutionizes the Paradigm of Echocardiography 3Health News:19th Annual Susan G. Komen National Race for the Cure(R) Draws Nearly 50,000 Participants, Celebrities; Brings Record Funds to National Capital Area 2Health News:19th Annual Susan G. Komen National Race for the Cure(R) Draws Nearly 50,000 Participants, Celebrities; Brings Record Funds to National Capital Area 3Health News:Renhuang Pharmaceuticals, Inc. Holds Trade Show for Tianma Pills; Signs Letters of Intent 2Health News:Renhuang Pharmaceuticals, Inc. Holds Trade Show for Tianma Pills; Signs Letters of Intent 3
Luria bertani broth: 1.0% Tryptone, 0.5% Yeast Extract, 1.0% Sodium Chloride....
2.5% Soytone, 4.8% Yeast Extract, 0.025% Magnesium Sulfate, 130mM Calcium Chloride....
... Off-white free flowing powder. pH: pH(4.7%, ... Casein Peptone: 24% Yeast Extract: 47% Potassium Phosphate ... To Use: Dissolve 47 gm powder per liter ... of plasmid DNA and recombinant proteins than LB ...
...
Medicine Products: